Pathogenesis of ascites in cirrhosis and portal hypertension

Medical Science Monitor

Volumn 6, Issue 4, 2000, Pages 807-816

  Heneghan, M A ^a   Harrison, P M ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Cirrhosis; Endothelin; Hepatorenal syndrome; Portal hypertension; Renin angiotensin aldosterone system

Indexed keywords

ENDOTHELIN; NORADRENALIN; RENIN; SODIUM; VASOPRESSIN;

ARTERIAL PRESSURE; ASCITES; DISEASE ASSOCIATION; HEART INDEX; HEPATORENAL SYNDROME; HUMAN; LIVER CIRRHOSIS; MEDIATOR RELEASE; PATHOGENESIS; PLASMA VOLUME; PORTAL HYPERTENSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SODIUM RETENTION; SYSTEMIC VASCULAR RESISTANCE; WATER RETENTION;

ARTERIES; ASCITES; BLOOD VOLUME; DIURESIS; HEART; HEMODYNAMIC PROCESSES; HEPATORENAL SYNDROME; HUMANS; HYPERTENSION, PORTAL; KIDNEY; LIVER CIRRHOSIS; LUNG; MODELS, BIOLOGICAL; NATRIURESIS; RENAL CIRCULATION; VASOCONSTRICTION;

EID: 0033856797     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Pathophysiology of water metabolism
2. Electrolyte patterns in patients with edema of different origins
3. Electrolyte studies on patients with cirrhosis of the liver
4. Sodium retention in dogs with cirrhosis and ascites: Efferent mechanisms
5. Temporal relationships between urinary salt retention and altered systemic hemodynamics in dogs with experimental cirrhosis
6. Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites
7. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites
8. Pathogenesis of ascites in cirrhosis
9. An explanation for experimental correction of the abnormal water diuresis in cirrhosis
10. Mechanism of increased renal tubular sodium reabsorption in cirrhosis
11. A micropuncture study of salt and water retention in chronic experimental cirrhosis
12. Renal sodium retention in cirrhosis: Relation to aldosterone and nephron site
13. Abnormalities in the excretion of water and sodium in compensated cirrhosis of the liver
14. Plasma volume in cirrhosis of the liver: Its relation to portal hypertension, ascites, and renal failure
15. Renal water and sodium handling in compensated liver cirrhosis: Mechanism of the impaired natriuresis after saline loading
16. Renal sodium retention in cirrhosis: Tubular site and relation to hepatic dysfunction
17. Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension
18. Renal failure in patients with cirrhosis of the liver. II. Factors influencing maximal urinary flow rate
19. Antidiuretic hormone and the pathogenesis of water retention in cirrhosis with ascites
20. Measurements of total body and extracellular water in cirrhotic patients with and without ascites
21. Prognostic value of spontaneous hyponatremia in cirrhosis with ascites
22. Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease
23. Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis
24. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis
25. Vasopressin in pathophysiological states
26. Renal failure in Laennec's cirrhosis of the liver: I. Description of clinical and laboratory features
27. The kidney in cirrhosis. I. Clinical and biochemical features of azotemia in hepatic failure
28. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis
29. Management of acute renal failure
30. Renal and intrarenal blood-flow in cirrhosis of the liver
31. Redistribution of renal blood flow in patients with liver cirrhosis. The role of renal PGE2
32. Renal failure in patients with cirrhosis of the liver. III. Evaluation of intrarenal blood flow by para-aminohippurate extraction and response to angiotensin
33. Renal dysfunction in hepatic disease: Early identification with renal duplex Doppler US in patients who undergo liver transplantation
34. Renal vasoconstriction in cirrhosis evaluated by duplex Doppler ultrasonography
35. Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis
36. Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites
37. Effect of V1-vasopressin receptor blockade on arterial pressure in conscious rats with cirrhosis and ascites
38. Circulating levels of endothelin in cirrhosis
39. Endothelin-1 and endothelin-3 in cirrhosis: Relations to systemic and splanchnic haemodynamics
40. Endothelin I does not play a major role in the homeostasis of arterial pressure in cirrhotic rats with ascites
41. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome
42. Atrial natriuretic factor in cirrhosis with ascites: Plasma levels, cardiac release and splanchnic extraction
43. Atrial natriuretic factor and liver disease
44. Plasma levels of brain natriuretic peptide in patients with cirrhosis
45. Renal effects of natriuretic peptide receptor blockade in cirrhotic rats with ascites
46. Digoxin-like immunoreactive substances in chronic liver disease
47. Sympathetic nervous activity, reninangiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion
48. Sulindac reduces the urinary excretion of prostaglandins and impairs renal function in cirrhosis with ascites
49. Effect of dipyridamole on kidney function in cirrhosis
50. Nitric Oxide and the Kidney
51. Increased endothelium-dependent renal vasodilation in cirrhotic rats
52. Pathogenesis of arterial hypotension in cirrhotic rats with ascites: Role of endogenous nitric oxide
53. Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis
54. Renal kallikrein excretion in cirrhotics with ascites: Relationship to renal hemodynamics
55. Renal kallikrein excretion in alcoholic cirrhosis. Relationship to other vasoactive systems
56. Role of renal kallikrein in the derangement of sodium and water derangement in cirrhotic patients
57. Body fluid volume regulation in health and disease: A unifying hypothesis
58. Collagenisation of the Disse space in alcoholic liver disease
59. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators
60. Enhanced vasoconstrictor response of the isolated perfused cirrhotic rat liver to humoral vasoconstrictor substances found in portal venous blood
61. Hepatic stellate (ITO) cells: Expanding roles for a liver-specific pericyte
62. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies
63. The stellate cell (Ito-cell, fat-storing cell, lipocyte, perisinusoidal cell) of the liver. New insights into pathophysiology of an intriguing cell
64. Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients
65. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus
66. Chronic ethanol consumption increases hepatic sinusoidal contractile response to endothelin-1 in the rat
67. Endothelin-1 induces direct constriction of hepatic sinusoids
68. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: Implications for regulation of portal pressure and resistance
69. Increased blood flow through the portal system in cirrhotic rats
70. Splenic artery and superior mesenteric artery blood flow: Nonsurgical Doppler US measurement in healthy subjects and patients with chronic liver disease
71. Intestinal capillary filtration in acute and chronic portal hypertension
72. Portal hypertension: A permissive factor only in the development of ascites and variceal bleeding
73. Is sinusoidal portal hypertension a necessary factor for the development of hepatic ascites?
74. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis
75. Impact of shunt surgery for variceal bleeding in the natural history of ascites in cirrhosis: A retrospective study
76. Should portosystemic shunt be reconsidered in the treatment of intractable ascites in cirrhosis?
77. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites
78. Hyperdynamic circulation in cirrhosis: A historical perspective
79. Hyperdynamic circulation of liver disease 40 years later: Pathophysiology and clinical consequences
80. Relationships between the severity of cirrhosis and haemodynamic values in patients with cirrhosis
81. Arteriovenous shunting, hemodynamic changes, and renal sodium retention in liver cirrhosis
82. Lymph imbalance in the genesis and perpetuation of the ascites syndrome in hepatic cirrhosis
83. Effective plasma volume in cirrhosis with ascites. Evidence that a decreased value does not account for renal sodium retention, a sponteneous reduction in glomerular filtration rate (GFR), and a fall in GFR during drug-induced diuresis
84. The relationship of plasma volume, portal hypertension, ascites and renal sodium retention in cirrhosis: The overflow theory of ascites formation
85. The onset of sodium retention in experimental cirrhosis in rats is related to a critical threshold of liver function
86. Reflex effects of hepatic baroreceptors on renal and cardiac sympathetic nerve activity
87. Hepatic denervation alters first-phase urinary sodium excretion in dogs with cirrhosis
88. Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis
89. Peripheral arterial vasodilatation: Determinant of functional spectrum of cirrhosis
90. Estimated central blood volume in cirrhosis: Relationship to sympathetic nervous activity, beta-adrenergic blockade and atrial natriuretic factor